Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Biopsy Devices Market Report Overview

The biopsy devices market size was $1.46 billion in 2023. Factors such as the increasing prevalence of cancer and a growing need for effective diagnostic procedures will drive the market growth at a CAGR of more than 3% during 2023-2033.

Biopsy is the basic standard technique preferred to interpret the diagnosis and characteristics of cancer. Tobacco use, alcohol use, unhealthy diet, and physical inactivity are the major risk factors causing cancer. Biopsies are also performed on non-cancerous indications such as chronic kidney disease (CKD), liver cirrhosis, and organ transplantations.

Biopsy Devices Market Outlook, 2023-2033 ($ Billion)

Biopsy Devices Market Outlook, 2023-2033 ($ Billion)

Buy the Full Report for More Insights into the Biopsy Devices Market Forecast
Download A Free Report Sample

The biopsy devices market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the biopsy devices market for 2020 and beyond. Furthermore, the report provides biopsy devices market share by company that will help in identifying untapped market opportunities.

Market Size (2023) $1.46 Billion
CAGR (2023-2033) >3%
Forecast period 2023-2033
Historical Period 2015-2022
Key Segments ·       Biopsy Forceps

·       Biopsy Guns

·       Biopsy Needles

·       Biopsy Punches

·       Vacuum-Assisted Needle Devices

Key Regions ·       North America

·       Europe

·       Asia Pacific

·       South Central America

·       Middle East and Africa

Leading Companies ·       Becton Dickinson and Co

·       Devicor Medical Products Inc

·       Hologic Inc

·       Cook Medical Inc

·       Boston Scientific Corp

·       Medtronic Plc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Biopsy Devices Market by Segments

The key segments in the biopsy devices market are Biopsy Forceps, Biopsy Guns, Biopsy Needles, Biopsy Punches, And Vacuum-Assisted Needle Devices. In 2023, the Biopsy Guns segment led the biopsy devices market. Biopsy Guns are handheld spring-loaded devices with core needles attached. The firing of the gun leads to the sampling of a small amount of core tissue that remains in the cannula of the attached needle. Biopsy Guns can be further sub-segmented into automatic Biopsy Guns and semiautomatic guns.

Vacuum-Assisted Needles Devices use a vacuum-powered system that aspirates several tissue samples. These devices do not rely on the spring-loading mechanism seen in Biopsy Guns. Reusable and Disposable Vacuum-Assisted Needle Devices are covered under this segment. While Biopsy Forceps are used in association with an endoscope to obtain biopsy samples.

Biopsy Devices Market Analysis by Segments, 2023 (%)

Biopsy Devices Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Biopsy Devices Market
Download A Free Report Sample

Biopsy Devices Market Segmentation by Regions

The key regions in the biopsy devices market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, the European biopsy device market had the highest share. Various countries within Europe run screening programs and registries to track disease cases. Germany and France have the largest share of the biopsy devices market in the region due to an increasing number of biopsy procedures and the adoption of newer devices.

German biopsy devices market follows global and regional trends for Europe. Factors such as advanced healthcare systems and the presence of local medical device companies rea driving the market growth. Substantial increases in cancer incidence and awareness of early diagnosis have also resulted in an increased number of biopsy procedures in Germany.

Biopsy Devices Market Analysis by Regions, 2023 (%)

Biopsy Devices Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Biopsy Devices Market
Download A Free Report Sample

Biopsy Devices Market - Competitive Landscape

In 2023, Becton Dickinson biopsy devices market share was the highest

A few of the leading companies in the biopsy devices market are:

  • Becton Dickinson and Co.
  • Devicor Medical Products Inc.
  • Hologic Inc.
  • Cook Medical Inc.
  • Boston Scientific Corp
  • Medtronic Plc

The key competitive strategies that major companies are following are offering diverse products and heavy investment in R&D among others. For instance, heavy R&D investment will lead to product innovation, which is a key driver of the biopsy devices market. In addition, higher accuracy rates, minimum contamination, less traumatic injury, and higher sample yield are key aspects of market growth.

Biopsy Devices Market Analysis by Companies, 2023 (%)

Biopsy Devices Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company Insights in the Biopsy Devices Market
Download A Free Report Sample

Biopsy Devices Market Dynamics

Trends: An increasing prevalence of cancer results in a growing need for effective diagnostic procedures, which is driving the biopsy device market growth. Demand for the MIS procedure has also positively impacted the biopsy devices market.

Future Outlook: Advances in technology, especially biopsy devices with advanced features, will result in safer procedures. Healthcare centers in various countries are encouraging patients to undergo diagnostic examinations to diagnose disease at an early stage. Government programs to promote diagnosis are further expected to improve the utilization of diagnostic devices.

Buy the Full Report for Additional Insights on the Biopsy Devices Market Dynamics, Download a Free Sample Report

Segments Covered in the Report

Biopsy Devices Segment Outlook (Value, $ Billion, 2015-2033)

  • Biopsy Forceps
    • Disposable Biopsy Forceps
    • Reusable Biopsy Forceps
  • Biopsy Guns
    • Automatic Biopsy Guns
    • Semiautomatic Guns
  • Biopsy Needles
    • Biopsy Gun Needles
    • Core Needles
    • Fine Needle Aspiration (FNA) Needles
    • Vacuum-Assisted Needles
  • Biopsy Punches
    • Disposable Biopsy Punches
    • Reusable Biopsy Punches
  • Vacuum-Assisted Needle Devices
    • Disposable Vacuum-Assisted Needle Devices
    • Reusable Vacuum-Assisted Needle Devices

Biopsy Devices Regional Outlook (Value, $ Billion, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South Central America
  • Middle East and Africa

Key Inclusions of the market model are:

The biopsy devices market research report includes an insightful review of the key industry trends.

  • The biopsy devices market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
  • The report also includes market-level data on units, average selling prices, and market values.

Regional, country, and global biopsy devices market insights:

  • The biopsy devices market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • Biopsy devices market SWOT analysis.
  • The report provides trends and Biopsy Devices market competitive dynamics.

Buy the Full Report for More Insights on the Biopsy Devices Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies covered: Becton Dickinson and Co, Danaher Corp, Hologic Inc, Cook Group Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Weigao Group Co Ltd, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, Steris Plc, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.


  • Extensive coverage of the biopsy devices market under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of the biopsy devices market and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Understand the COVID-19 impact on biopsy devices.
  • Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving biopsy devices.
  • Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
  • Formulate effective sales and marketing strategies with a detailed evaluation of biopsy devices market share by company. Identify strong competitors and create winning strategies to stand out in the global biopsy devices market.
  • Track regional biopsy devices market sales as well as country-specific transactions from 2015-2033.
  • Organize your sales and marketing efforts by identifying the global biopsy devices market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.

Frequently asked questions

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 standard reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 in real time.

  • Access a live Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.